Global CBD API Market

Report ID : 1478 | Published : 2022-12-12 | Pages: 180 | Format: PDF/EXCEL

The market size of the Global CBD API Market is predicted to register a CAGR of 41.7% during the forecast period of 2022-2030. Cannabidiol (CBD) is a cannabis-derived chemical that occurs naturally. While cannabis includes over one hundred distinct cannabinoids, such as tetrahydrocannabinol (THC) and lesser cannabinoids, such as CBN and CBG, CBD is the most well-known. CBD binds to multiple cell receptors throughout the body, directly and indirectly revealing its extensive medicinal potential. Cannabidiol (CBD) research is developing rapidly, providing clinical support for the human body, mind, and emotions. Each cannabinoid possesses unique characteristics, medicinal capabilities, chemical structure, and advantages. CBD is frequently extracted and manufactured into CBD-based oils, tinctures, topical creams, and edibles due to its versatility and well-tolerated nature. All cannabinoids produce therapeutic effects through interaction with the endocannabinoid system (ECS), and CBD is not dissimilar. The ECS is a complex cell signalling system in all animals, composed of endocannabinoids and receptors. CBD regulates a variety of biological processes, including pain perception, emotion, sleep, and immunological response. Cannabidiol is very sensitive for the human body as it shows various side effects. EPIDIOLEX is the first prescription CBD product approved by the FDA for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome, or tuberous sclerosis complex (TSC) in individuals aged one year and older. It implies that clinical trials have thoroughly examined its safety and efficacy profile.

The market is primarily driven by the rising demand for Cannabidiol (CBD) for health and well-being applications. Cannabidiol is beneficial for treating anxiety and seizures and lowering pain. Due to the absence of psychotropic effects, Cannabidiol is the cannabinoid most commonly used for therapeutic purposes, and it is in great demand for health and wellness purposes, which is the primary market driver. In addition, the increasing acceptability and use of products as a result of regulatory approvals is a significant driver that is anticipated to increase the manufacturing of CBD-infused products. In addition, government funding for therapeutic research and collaborations with prominent market players will enhance the development and demand for CBD as an API.

As CBD is a very delicate chemical compound for therapeutic use, FDA is approving CBD-derived drugs very carefully; hence only one drug has been approved yet. Such delays in approvals will impact the global demand for CBD as an API. The high cost of this market is the most significant obstacle they face. Since they are associated with medical advantages and necessitate extensive research to prepare products, they are unaffordable to most of the population. This is a crucial impediment to the expansion of the CBD business.

The CBD API market is segmented into three segments. The first segment is by product, including Full spectrum CBD, Broad-spectrum CBD, CBD isolate, and Others. The other segment is by Origin, which has two divisions, synthetic and natural, in which natural Origin is very much demanding in the current market. The third segment is Indication, which comprises Alzheimer's Disease, Autism, Cancer, Chronic Pain, Epilepsy, Psychosis, Anxiety & Depression, Obesity/weight loss, and Others.

Regionally, North America dominated the Cannabidiol (CBD) API market, which is anticipated to continue during the forecast period. Most of the CBD providers are present in the North American region, and the investments are at the peak for research and development on Cannabidiol-derived therapies.

The prominent market players are Recipharm, brains bioceutical, Purisys, DSM, Bedrocan, CBD API, Vantage Hemp, Eurofins, BIOVECTRA Inc., EndoPure, Biosyyd, UAB, KD Pharma Group, Folium Biosciences, Kinetochem, Colombian Golden, Averix Bio, LLC, Veranova, KND Labs, Jordan Process, GVB Biopharma, and Other key players.

  • Recipharm
  • brains bioceutical
  • Purisys
  • DSM
  • Bedrocan
  • CBD API
  • Vantage Hemp
  • Eurofins
  • BIOVECTRA Inc.
  • EndoPure
  • Biosyyd, UAB
  • KD Pharma Group
  • Folium Biosciences
  • Kinetochem
  • Colombian Golden
  • Averix Bio, LLC
  • Veranova
  • KND Labs
  • Jordan Process
  • GVB Biopharma

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Cannabidiol (CBD) API Market Snapshot

Chapter 4. Global Cannabidiol (CBD) API Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: By Origin, Estimates & Trend Analysis

5.1. By Origin, & Market Share, 2020 & 2030

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Origin:

5.2.1. Natural

5.2.2. Synthetic

Chapter 6. Market Segmentation 2: By Products Estimates & Trend Analysis

6.1. By Products & Market Share, 2020 & 2030

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Products:

6.2.1. Full spectrum CBD

6.2.2. Broad-spectrum CBD

6.2.3. CBD isolate

6.2.4. Water Dispersible CBD Powder

6.2.5. Other Products

Chapter 7. Market Segmentation 3: By Indication Estimates & Trend Analysis

7.1. By Indication & Market Share, 2020& 2030

7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Indication:

7.2.1. Alzheimer’s Disease

7.2.2. Autism

7.2.3. Cancer

7.2.4. Chronic Pain

7.2.5. Epilepsy

7.2.6. Migraine

7.2.7. Multiple Sclerosis

7.2.8. Schizophrenia

7.2.9. Other Indications

Chapter 8. Market Segmentation 4: By End-Users Estimates & Trend Analysis

8.1. By End-Users & Market Share, 2020& 2030

8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By End-Users:

8.2.1. Pharmaceutical Industry

8.2.2. Academic & Clinical Research Institutes

Chapter 9. Cannabidiol (CBD) API Market Segmentation 5: Regional Estimates & Trend Analysis

9.1. North America

9.1.1. North America Cannabidiol (CBD) API Market revenue (US$ Million) estimates and forecasts By Origin, 2022-2030

9.1.2. North America Cannabidiol (CBD) API Market revenue (US$ Million) estimates and forecasts By Products, 2022-2030

9.1.3. North America Cannabidiol (CBD) API Market revenue (US$ Million) estimates and forecasts By Indication, 2022-2030

9.1.4. North America Cannabidiol (CBD) API Market revenue (US$ Million) estimates and forecasts By End-Users, 2022-2030

9.1.5. North America Cannabidiol (CBD) API Market revenue (US$ Million) estimates and forecasts by country, 2022-2030

9.2. Europe

9.2.1. Europe Cannabidiol (CBD) API Market revenue (US$ Million) By Origin, 2022-2030

9.2.2. Europe Cannabidiol (CBD) API Market revenue (US$ Million) By Products, 2022-2030

9.2.3. Europe Cannabidiol (CBD) API Market revenue (US$ Million) By Indication, 2022-2030

9.2.4. Europe Cannabidiol (CBD) API Market revenue (US$ Million) estimates and forecasts By End-Users, 2022-2030

9.2.5. Europe Cannabidiol (CBD) API Market revenue (US$ Million) by country, 2022-2030

9.3. Asia Pacific

9.3.1. Asia Pacific Cannabidiol (CBD) API Market revenue (US$ Million) By Origin, 2022-2030

9.3.2. Asia Pacific Cannabidiol (CBD) API Market revenue (US$ Million) By Products, 2022-2030

9.3.3. Asia Pacific Cannabidiol (CBD) API Market revenue (US$ Million) By Indication, 2022-2030

9.3.4. Asia Pacific Cannabidiol (CBD) API Market revenue (US$ Million) estimates and forecasts By End-Users, 2022-2030

9.3.5. Asia Pacific Cannabidiol (CBD) API Market revenue (US$ Million) by country, 2022-2030

9.4. Latin America

9.4.1. Latin America Cannabidiol (CBD) API Market revenue (US$ Million) By Origin, (US$ Million) 2022-2030

9.4.2. Latin America Cannabidiol (CBD) API Market revenue (US$ Million) By Products, (US$ Million) 2022-2030

9.4.3. Latin America Cannabidiol (CBD) API Market revenue (US$ Million) By Indication, (US$ Million) 2022-2030

9.4.4. Latin America Cannabidiol (CBD) API Market revenue (US$ Million) estimates and forecasts By End-Users, 2022-2030

9.4.5. Latin America Cannabidiol (CBD) API Market revenue (US$ Million) by country, 2022-2030

9.5. Middle East & Africa

9.5.1. Middle East & Africa Cannabidiol (CBD) API Market revenue (US$ Million) By Origin, (US$ Million) 2022-2030

9.5.2. Middle East & Africa Cannabidiol (CBD) API Market revenue (US$ Million) By Products, (US$ Million) 2022-2030

9.5.3. Middle East & Africa Cannabidiol (CBD) API Market revenue (US$ Million) By Indication, (US$ Million) 2022-2030

9.5.4. Middle East & Africa Cannabidiol (CBD) API Market revenue (US$ Million) estimates and forecasts By End-Users, 2022-2030

9.5.5. Middle East & Africa Cannabidiol (CBD) API Market revenue (US$ Million) by country, 2022-2030

Chapter 10. Competitive Landscape

10.1. Major Mergers and Acquisitions/Strategic Alliances

10.2. Company Profiles

10.2.1. Recipharm

10.2.2. brains bioceutical

10.2.3. Purisys

10.2.4. DSM

10.2.5. Bedrocan

10.2.6. CBD API

10.2.7. Vantage Hemp

10.2.8. Eurofins

10.2.9. BIOVECTRA Inc.

10.2.10. EndoPure

10.2.11. Biosyyd, UAB

10.2.12. KD Pharma Group

10.2.13. Folium Biosciences

10.2.14. Kinetochem

10.2.15. Colombian Golden

10.2.16. Averix Bio, LLC

10.2.17. Veranova

10.2.18. KND Labs

10.2.19. Jordan Process

10.2.20. GVB Biopharma

10.2.21. Farmakem d.o.o.

10.2.22. Kare Chemical Technologies Inc.

10.2.23. CBDepot s.r.o

10.2.24. Other Prominent Players

Global CBD API Market, by Product, 2022-2030 (Value US$ Mn)

  • Full spectrum CBD
  • Broad-spectrum CBD
  • CBD isolate
  • Water Dispersible CBD Powder
  • Others

 Global CBD API Market, by Origin, 2022-2030 (Value US$ Mn)

  • Natural
  • Synthetic

Global CBD API Market, by Indication, 2022-2030 (Value US$ Mn)

  • Alzheimer's Disease
  • Autism
  • Cancer
  • Chronic Pain
  • Epilepsy
  • Migraine
  • Multiple Sclerosis
  • Schizophrenia
  • Others

Global CBD API Market, by End-User, 2022-2030 (Value US$ Mn)

  • Pharmaceutical Industry
  • University and Research Institutes
  • Others

Global CBD API Market, by Region, 2022-2030 (Value US$ Mn)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

North America CBD API Market, by Country, 2022-2030 (Value US$ Mn)

  • U.S.
  • Canada

Europe CBD API Market, by Country, 2022-2030 (Value US$ Mn)

  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Asia Pacific CBD API Market, by Country, 2022-2030 (Value US$ Mn)

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America CBD API Market, by Country, 2022-2030 (Value US$ Mn)

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa CBD API Market, by Country, 2022-2030 (Value US$ Mn)

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Complete Report ?
Our Clients